Stock info Hologic | Filter  Basic-Info

Hologic

The past year was a relatively good year for Hologic investors

The period between December 2015 and December 2016 was a good period for the investors. The stock gained almost 4 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 136 percent. Hologic's revenues between 2011 and 2015 were very volatile through the time and moved between 2 billion dollars and 2,71 billion dollars. The net results between 2011 and 2015 were very constant and fluctuated between 157,15 million dollars and 131,6 million dollars.

Hologic has located her head office Marlborough. Hologic primarily operates in the health care eq. & services sector. Stephen P. MacMillan is the CEO of the company. Hologic has Bob McMahon as CFO financial responsible for the company. The global health care companies gained around 102 percent over the period 2006-2016. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.

Over the past 5 years the American company paid out dividends.

Hologic' balance mostly consists of equity

At the end of 2015 the American company had a balance sheet of around 7,67 billion dollars. The total debt of the health care company was at the end of 2015 5,59 billion dollars, which equals around 72,89 percent of the total balance sheet. At the end of 2015 the health care company's stock was traded with a price/earnings-ratio 38. So the stock' value was 38 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 10,73 billion dollars. At the end of 2015 around 282,5 million stocks were listed.

All the annual reports of Hologic are available here. More information about Hologic can be found it's website. .